Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

Michael Walter | January 21, 2025 | Cardiovascular Business | Interventional Cardiology

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Intravascular lithotripsy in action. Image courtesy of Shockwave Medical, a part of Johnson & Johnson MedTech.

Intravascular lithotripsy (IVL) has quickly emerged as one of healthcare’s most in-demand technologies, allowing cardiologists to safely break up heavily calcified plaques and prepare patients for percutaneous coronary intervention (PCI).

Now Shockwave Medical, a part of Johnson & Johnson MedTech, is co-hosting a new webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures.

The webinar, 2025 Shockwave IVL Reimbursement Overview, is scheduled for Jan. 29 at 2:30 p.m. ET. It will cover key details about how IVL technology works and provide updated information on how care teams should bill for IVL to ensure they receive the highest reimbursements possible. Attendees will then be able to participate in a live Q&A session.

Three IVL specialists are participating in the upcoming event:

Sarang Mangalmurti, MD, an interventional cardiologist with Bryn Mawr Medical Specialists and Main Line Health.
Eric Hoesing, RN, BSN, MBA, a field reimbursement manager with Shockwave Medical.
Sue Michalic, RN, MS, a field reimbursement manager with Shockwave Medical.

In addition to coding and billing specialists, this webinar is targeted toward interventional cardiologists, cardiology and interventional cardiology chiefs, cardiovascular service line directors, hospital and health system executives and anyone else hoping to learn more about this plaque-busting technology.

Click here to register for the event for free. Attendees will receive 1.0 AAPC CEU for participating.

Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients

Intravascular lithotripsy, the technology at heart of $13B acquisition, linked to positive real-world data

It’s official: Johnson & Johnson completes $13B Shockwave Medical acquisition

‘Your heart belongs here’: Improved device, economics help cardiologists keep more patients close to home

Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.